Distribution of regional lymph nodes metastasis in 870 cases of nasopharyngeal carcinoma and the suggestions for individualized elective prophylactic neck irradiation with intensity-modulated radiotherapy
- PMID: 38156901
- PMCID: PMC10905225
- DOI: 10.1002/cam4.6723
Distribution of regional lymph nodes metastasis in 870 cases of nasopharyngeal carcinoma and the suggestions for individualized elective prophylactic neck irradiation with intensity-modulated radiotherapy
Abstract
Purpose: To explore the feasibility of individualized elective prophylactic neck irradiation (iEPNI) for optimizing current approach by investigating metastatic lymph nodes (LNs) distribution in nasopharyngeal carcinoma (NPC).
Materials and methods: Records of 870 NPC patients without distant metastasis in Hunan Cancer Hospital from January 2019 to December 2019 were reviewed. LNs' locations were identified based on the 2013 guidelines. The intra-regional lymphatic drainage (IRLD) areas included Station 1st (level VIIa and II), Station 2nd (level III and Va), and Station 3rd (level IV, Vb, and Vc). Other levels were categorized as extra-regional areas.
Results: Among the 870 patients, 94.5% cases exhibited LNs metastasis, including unilateral metastasis in 198 patients and bilateral metastasis in 624 patients. In the whole cohort, the most common involved IRLD areas were level IIb (87.1%), VIIa (80.0%), IIa (61.8%), Va (30.6%), IV (21.4%), Vb (8.9%), and Vc (1.1%). Besides, rates of LNs metastasis in Station 1st, 2nd, and 3rd were 94.3%, 61.1%, and 22.9%, respectively. Only four patients (4, 0.5%) revealed skipping metastasis among the three stations.
Conclusions: Lymph node metastasis follows an organized pattern from Station 1st to 3rd with scarce skipping metastasis. A potential iEPNI strategy of prophylactic neck irradiation to the ipsilateral latter node-negative station appears promising in NPC patients. Further prospective investigations are warranted to validate the approach.
Keywords: elective prophylactic neck irradiation; intensity-modulated radiotherapy; lymph nodes distribution; nasopharyngeal carcinoma.
© 2023 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
Not applicable.
Figures


Similar articles
-
Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.Cancer Med. 2023 Nov;12(21):20511-20520. doi: 10.1002/cam4.6614. Epub 2023 Oct 25. Cancer Med. 2023. PMID: 37881136 Free PMC article.
-
Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.Auris Nasus Larynx. 2019 Jun;46(3):457-464. doi: 10.1016/j.anl.2018.10.012. Epub 2018 Dec 6. Auris Nasus Larynx. 2019. PMID: 30528104
-
Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.BMC Cancer. 2020 Jul 17;20(1):667. doi: 10.1186/s12885-020-07146-z. BMC Cancer. 2020. PMID: 32680466 Free PMC article.
-
Feasibility of ipsilateral lower neck sparing irradiation for unilateral or bilateral neck node-negative nasopharyngeal carcinoma: systemic review and meta-analysis of 2, 521 patients.Radiat Oncol. 2018 Aug 6;13(1):141. doi: 10.1186/s13014-018-1087-x. Radiat Oncol. 2018. PMID: 30081932 Free PMC article.
-
Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence.BMC Cancer. 2012 Mar 21;12:98. doi: 10.1186/1471-2407-12-98. BMC Cancer. 2012. PMID: 22433671 Free PMC article. Review.
Cited by
-
A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting.Discov Oncol. 2025 Apr 9;16(1):496. doi: 10.1007/s12672-025-02242-7. Discov Oncol. 2025. PMID: 40202582 Free PMC article.
-
High Expression of GPR183 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia.Biochem Genet. 2025 Jan 16. doi: 10.1007/s10528-025-11026-1. Online ahead of print. Biochem Genet. 2025. PMID: 39820826
-
A prognostic nomogram based on lymph node skipping metastases in esophageal squamous cell carcinoma.J Thorac Dis. 2025 Apr 30;17(4):1942-1957. doi: 10.21037/jtd-24-1798. Epub 2025 Apr 27. J Thorac Dis. 2025. PMID: 40400938 Free PMC article.
-
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.Mol Cell Biochem. 2024 Dec;479(12):3229-3254. doi: 10.1007/s11010-024-04933-1. Epub 2024 Feb 28. Mol Cell Biochem. 2024. PMID: 38413478 Review.
-
PTEN as a prognostic factor for radiotherapy plus immunotherapy response in nasopharyngeal carcinoma.J Nanobiotechnology. 2025 Apr 21;23(1):303. doi: 10.1186/s12951-025-03315-z. J Nanobiotechnology. 2025. PMID: 40259377 Free PMC article.
References
-
- Pfister DG, Spencer S, Adkins D, et al. NCCN clinical practice guidelines in oncology (NCCN guidelines®). Head and Neck Cancers. 2023, Version 1. 2023. - PubMed
-
- Ou D, Blanchard P, El Khoury C, et al. Induction chemotherapy with docetaxel, cisplatin and fluorouracil followed by concurrent chemoradiotherapy or chemoradiotherapy alone in locally advanced non‐endemic nasopharyngeal carcinoma. Oral Oncol. 2016;62:114‐121. doi:10.1016/j.oraloncology.2016.10.011 - DOI - PubMed
-
- Sun X, Su S, Chen C, et al. Long‐term outcomes of intensity‐modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2014;110(3):398‐403. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources